Almdal T P, Petersen K F, Hansen B A, Vilstrup H
Diabetologia. 1986 Nov;29(11):812-6. doi: 10.1007/BF00873222.
Diabetes was induced in Wistar rats by intravenous streptozotocin, 75 mg/kg. Four and 14 days after streptozotocin, fasting insulin decreased to about one-third, and fasting glucagon increased three-fold. The urea-N synthesis rate, stimulated by infusion of alanine, was measured at different amino acid concentrations 14 days after streptozotocin in 24 rats. The relationship was compatible with a barrier limited substrate inhibition kinetics. Data were examined accordingly by non-linear regression analysis. Among the estimated kinetic constants, only the 70% increase in Vmax was different from control values. In control rats the capacity of urea nitrogen synthesis, as measured within the amino acid concentration interval 7.3-11.6 mmol/l, was 10.2 +/- 1.1 mumol . (min 100 g BW)-1 (mean +/- SEM). The capacity was not different in 4 day diabetic rats, whereas it doubled in 14 day diabetic rats, 20.9 +/- 1.7 mumol (min 100 g BW)-1. The alanine elimination rate was 35% higher in the 14 day diabetic rats compared both to 4 day diabetic and control rats. The increase of urea synthesis is suggested to be due to enzyme induction by glucagon. The net nitrogen balance was negative at amino acid concentrations up to 25 mmol/l, indicating that the urea synthesis was increased at the expense of amino nitrogen.
通过静脉注射链脲佐菌素(75毫克/千克)诱导Wistar大鼠患糖尿病。链脲佐菌素注射后4天和14天,空腹胰岛素降至约三分之一,空腹胰高血糖素增加了两倍。在链脲佐菌素注射14天后,对24只大鼠在不同氨基酸浓度下测量了丙氨酸输注刺激的尿素氮合成速率。这种关系符合屏障限制底物抑制动力学。相应地通过非线性回归分析检查数据。在估计的动力学常数中,只有Vmax增加70%与对照值不同。在对照大鼠中,在氨基酸浓度区间7.3 - 11.6毫摩尔/升内测量的尿素氮合成能力为10.2±1.1微摩尔·(分钟·100克体重)-1(平均值±标准误)。4天糖尿病大鼠的能力没有差异,而14天糖尿病大鼠的能力增加了一倍,为20.9±1.7微摩尔·(分钟·100克体重)-1。与4天糖尿病大鼠和对照大鼠相比,14天糖尿病大鼠的丙氨酸消除率高35%。尿素合成的增加被认为是由于胰高血糖素诱导酶所致。在氨基酸浓度高达25毫摩尔/升时,净氮平衡为负,表明尿素合成增加是以氨基酸氮为代价的。